Causaly announced an expansion of its collaboration with Microsoft (NASDAQ: MSFT) to integrate agentic scientific research capabilities directly into Microsoft Copilot for enterprise life sciences teams. Enterprise scientists and knowledge workers can now access Causaly’s scientifically grounded research within Microsoft 365 workflows, including the Copilot app and Microsoft Teams. The integration lets Causaly act as a specialized enterprise agent orchestrating end-to-end scientific research, invoked from the agent menu or by @mentioning Causaly in a Copilot conversation. Every answer carries traceable references to peer-reviewed literature, biomedical databases, and Causaly’s proprietary knowledge graphs, Bio Graph and Pipeline Graph. The announcement builds on a collaboration first unveiled at Microsoft Build 2026 in June, which brought Causaly’s scientific interpretation together with Microsoft Discovery’s enterprise scientific platform. Yiannis Kiachopoulos, co-founder and CEO of Causaly, said the move puts governed, provenance-first scientific reasoning inside the same interface used across research, development, medical, and commercial functions in biopharma, extending the June deployment on Microsoft Discovery to Microsoft Copilot. Chantrelle Neilsen, principal product manager for Microsoft 365 Copilot at Microsoft, described the integration as a model for specialized enterprise agents inside Copilot. Causaly is currently available on the Microsoft Marketplace, with the integration designed to support evidence-grounded research workflows across Microsoft Discovery and Microsoft Copilot.